Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3

Journal of Hepatology

Volumn 33, Issue 1, 2000, Pages 106-115

  Rubbia Brandt, Laura ^a   Quadri, Rafael ^b   Abid, Karim ^b   Giostra, Emiliano ^b   Malé, Pierre Jean ^b   Mentha, Gilles ^c   Spahr, Laurent ^b   Zarski, Jean Pierre ^d   Borisch, Bettina ^a   Hadengue, Antoine ^b   Negro, Francesco ^a,b,e  

^a Clinical Pathology   (Switzerland)

^b Division of Gastroenterology and Hepatology   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d UNIV GRENOBLE ALPES   (France)

^e Div Gastroenterol Hepatol U   (Switzerland)

Author keywords

Liver steatosis; Sequence heterogeneity; Viral cytopathic effect; Viral pathogenesis

Indexed keywords

ADULT; ARTICLE; CYTOPATHOGENIC EFFECT; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS TYPING;

EID: 0033933140     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80166-X     Document Type: Article

References (42)

1. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med. 327:1991;1906-1911.
2. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology. 15:1992;567-571.
3. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 15:1992;572-577.
4. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis. 15:1995;70-81.
5. Fischer HP, Willsch E, Bierhoff E, Pfeifer U. Histopathologic findings in chronic hepatitis C. J Hepatol. 24:1996;35-42.
6. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology. 25:1997;735-739.
7. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 105:1993;1824-1832.
8. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 29:1998;198-206.
9. Haruna Y, Hayashi N, Hiramatsu N, Takehara T, Hagiwara H, Sasaki Y, et al. Detection of hepatitis C virus RNA in liver tissues by an in situ hybridization technique. J Hepatol. 18:1993;96-100.
10. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA. 94:1997;1200-1205.
11. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol. 78:1997;1527-1531.
12. Negro F, Giostra E, Krawczynski K, Quadri R, Rubbia-Brandt L, Mentha G, et al. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR. Preliminary application to the liver transplantation model. J Hepatol. 29:1998;1-11.
13. Negro F, Krawczynski K, Quadri R, Rubbia-Brandt L, Mondelli M, Zarski JP, et al. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semi-quantitative RT-PCR. Hepatology. 29:1999;536-542.
14. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12:1990;1106-1110.
15. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 126:1997;137-145.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
17. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SG, et al. The predictive value of donor liver biopsies for the development of primary non-function after orthotopic liver transplantation. Transplantation. 51:1991;157-163.
18. Deugnier YM, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology. 17:1993;30-34.
19. Turlin B, Deugnier Y. Histological assessment of liver siderosis. J Clin Pathol. 50:1997;971.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
21. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA. 82:1985;6133-6137.
22. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol. 76:1995;1197-1204.
23. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
24. Negro F, Rubbia-Brandt L, Giostra E, Seium Y, Mentha G, Quadri R, et al. Hepatitis G virus infection among liver graft recipients: anatomoclinical correlations. Dig Dis Sci. 43:1998;2577-2583.
25. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucl Acids Res. 16:1988;10881-10890.
26. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human. T-cell line. 89:1992;5477-5481.
27. Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G, et al. Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg. 4:1998;441-447.
28. Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, et al. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology. 25:1997;1014-1021.
29. Matsuda J, Suzuki M, Nozaki C, Shinya N, Tashiro K, Mizuno K, et al. Transgenic mouse expressing a full-length hepatitis C virus cDNA. Jpn J Cancer Res. 89:1998;150-158.
30. Pasquinelli C, Shoenberger JM, Chung J, Chang KM, Guidotti LG, Selby M, et al. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology. 25:1997;719-727.
31. Moradpour D, Engler C, Wakita T, Wands JR. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology. 222:1996;51-63.
32. Santolini E, Migliaccio G, La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 68:1994;3631-3641.
33. Francesconi R, Giostra F, Ballardini G, Manzin A, Solforosi L, Lari F, et al. Clinical implications of GBV-C/HGV infection in patients with"HCV-related" chronic hepatitis. J Hepatol. 26:1997;1165-1172.
34. Petrik J, Guella L, Wight DG, Pearson GM, Hinton J, Parker H, et al. Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus. Gut. 42:1998;103-106.
35. Cacopardo B, Berger A, Cosentino S, Boscia V, Vinci G, Restivo R, et al. Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C. Eur J Clin Microbiol Infect Dis. 17:1998;709-714.
36. Pappo I, Bercovier H, Berry E, Gallilly R, Feigin E, Freund HR. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. JPEN J Parenter Enteral Nutr. 19:1995;80-82.
37. Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferators-activated receptor alpha natural ligand metabolism. J Biol Chem. 273:1998;15639-15645.
38. Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem. 273:1998;29577-29585.
39. Lanza-Jacoby S, Rosato EL. Regulatory factors in the development of fatty infiltration of the liver during gram-negative sepsis. Metabolism. 43:1994;691-696.
40. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, et al. Iron storage, lipid peroxydation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
41. Haque S, Chandra B, Gerber MA, Lok ASF. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol. 27:1996;1277-1281.
42. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology. 29:1999;1215-1219.